EBIT: Income before interest and taxes.
Tevogen Bio Holdings Inc. (TVGN) had EBIT of $-26.14M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.83M |
|
-- |
|
-- |
|
$26.14M |
|
$-26.14M |
|
$-0.13M |
|
$-26.28M |
|
$-26.28M |
|
$-26.28M |
|
$-26.28M |
|
$-26.28M |
|
$-26.28M |
|
|
EBIT |
$-26.14M |
$-25.63M |
|
3.32M |
|
3.32M |
|
$-8.08 |
|
$-8.08 |
|
| Balance Sheet Financials | |
$1.54M |
|
$0.17M |
|
$2.84M |
|
$4.38M |
|
$7.07M |
|
$4.40M |
|
$5.55M |
|
$12.62M |
|
$-17.03M |
|
$-8.23M |
|
$-8.23M |
|
4.02M |
|
| Cash Flow Statement Financials | |
$-12.33M |
|
$-0.06M |
|
$11.66M |
|
$1.28M |
|
$0.55M |
|
$-0.73M |
|
$16.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.22 |
|
-- |
|
-- |
|
-1.15 |
|
-0.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
154.25% |
|
319.08% |
|
-599.49% |
|
685.20% |
|
$-2.05 |
|
$-3.73 |
|
$-3.71 |
|